Biotech & Healthtech · Veta Health · AI-enabled virtual care
Commercial model & EU entry · Digital health · 2021

Situation
Veta Health had a remote-care platform clinicians trusted; a peer-reviewed trial showed 78% lower 45-day readmission for heart-failure patients. What it lacked was a defined buyer, a business model and a route into Europe.
JetPack's role
Outcome
Veta reported 130% customer growth in 2021, doubled its team across the US and Europe, and added partnerships including Roche Diagnostics, the Netherlands Heart Network and Twilio. Growth and partnership outcomes are as reported by Veta Health; the clinical result validates the product, not the consulting work.


If the story, numbers or diligence process aren't where they need to be yet, that's where we come in.
